Skip to main content
Erschienen in: Urolithiasis 1/2008

01.02.2008 | Original Paper

A traditional Chinese herbal antilithic formula, Wulingsan, effectively prevents the renal deposition of calcium oxalate crystal in ethylene glycol-fed rats

verfasst von: Chou-Huang Tsai, Yu-Cheng Chen, Lieh-Der Chen, Tien-Chien Pan, Chien-Yi Ho, Ming-Tsung Lai, Fuu-Jen Tsai, Wen-Chi Chen

Erschienen in: Urolithiasis | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

We investigated the effects of a traditional Chinese herbal formula, Wulingsan (WLS), on renal stone prevention using an ethylene glycol-induced nephrocalcinosis rat model. Forty-one male Sprague-Dawley (SD) rats were divided into four groups. Group 1 (n = 8) was the normal control; group 2 (n = 11) served as the placebo group, and received a gastric gavage of starch and 0.75% ethylene glycol (EG) as a stone inducer; group 3 received EG and a low dose of WLS (375 mg/kg); and group 4 received EG and a high dose of WLS (1,125 mg/kg). Baseline and final 24 h urine samples were collected individually; biochemical data of urine and serum were also obtained at the beginning and at the end of the experiment. After 4 weeks, animals were killed and kidneys were harvested. The kidney specimens were examined by polarized light microscopy and the crystal deposits were evaluated by a semi-quantitative scoring method using computer software (ImageScoring). The results revealed that the rats of placebo group gained the least significant body weight; in contrast, the rats of WLS-fed groups could effectively reverse it. The placebo group exhibited lower levels of free calcium (p = 0.059) and significantly lower serum phosphorus (p = 0.015) in urine than WLS-fed rats. Histological findings of kidneys revealed tubular destruction, damage and inflammatory reactions in the EG-water rats. The crystal deposit scores dropped significantly in the WLS groups, from 1.40 to 0.46 in the low-dose group and from 1.40 to 0.45 in the high-dose group. Overall, WLS effectively inhibited the deposition of calcium oxalate (CaOx) crystal and lowered the incidence of stones in rats (p = 0.035). In conclusion, WLS significantly reduced the severity of calcium oxalate crystal deposits in rat kidneys, indicating that Wulingsan may be an effective antilithic herbal formula.
Literatur
3.
Zurück zum Zitat Ho SZ, Kuo HC (2002) Pathogenesis and epidemiology of urolithiasis. Tzu Chin Med J 14:337–346 Ho SZ, Kuo HC (2002) Pathogenesis and epidemiology of urolithiasis. Tzu Chin Med J 14:337–346
4.
Zurück zum Zitat Menon M, Resnick MI (2002) Urinary lithiasis: etiology, diagnosis, and medical management. In: Walsh PC, Retik AB, Vaughan ED Jr., Wein AJ (eds) Campbell’s urology. 8th ed. WB Saunders, Philadelphia Menon M, Resnick MI (2002) Urinary lithiasis: etiology, diagnosis, and medical management. In: Walsh PC, Retik AB, Vaughan ED Jr., Wein AJ (eds) Campbell’s urology. 8th ed. WB Saunders, Philadelphia
5.
Zurück zum Zitat Lee YH, Huang WC, Tsai JY (2002) Epidemiological studies on the prevalence of upper urinary calculi in Taiwan. Urol Int 68:172–177PubMedCrossRef Lee YH, Huang WC, Tsai JY (2002) Epidemiological studies on the prevalence of upper urinary calculi in Taiwan. Urol Int 68:172–177PubMedCrossRef
6.
Zurück zum Zitat Kim HH, Jo MK, Kwak C, Park SK, Yoo KY, Kang D, Lee C (2002) Prevalence and epidemiologic characteristics of urolithiasis in Seoul, Korea. Urology 59:517–521PubMedCrossRef Kim HH, Jo MK, Kwak C, Park SK, Yoo KY, Kang D, Lee C (2002) Prevalence and epidemiologic characteristics of urolithiasis in Seoul, Korea. Urology 59:517–521PubMedCrossRef
7.
Zurück zum Zitat Yoshida O, Terai A, Ohkawa T, Okada Y (1999) National trend of the incidence of urolithiasis in Japan from 1965 to 1995. Kidney Int 56:1899–1904PubMedCrossRef Yoshida O, Terai A, Ohkawa T, Okada Y (1999) National trend of the incidence of urolithiasis in Japan from 1965 to 1995. Kidney Int 56:1899–1904PubMedCrossRef
10.
Zurück zum Zitat Cao ZG, Liu JH, Zhou SW (2004) Effect of alisma orientalis extract on renal stone formation and the expression of inter-alpha-trypsin inhibitor in rat urolithiasis model. Chin J Exp Surg 21:295–297 Cao ZG, Liu JH, Zhou SW (2004) Effect of alisma orientalis extract on renal stone formation and the expression of inter-alpha-trypsin inhibitor in rat urolithiasis model. Chin J Exp Surg 21:295–297
11.
Zurück zum Zitat Liu QL, Sato S, Kishikawa T (2001) Effectiveness of a traditional Chinese medicine, Wulingsan, in suppressing the development of nephrocalcinosis induced by a high phosphorus diet in young rats. Med Electron Microsc 34: 103–114PubMedCrossRef Liu QL, Sato S, Kishikawa T (2001) Effectiveness of a traditional Chinese medicine, Wulingsan, in suppressing the development of nephrocalcinosis induced by a high phosphorus diet in young rats. Med Electron Microsc 34: 103–114PubMedCrossRef
12.
Zurück zum Zitat Hattori T, Hayashi K, Nagao T (1992) Studies on antinephritic effects of plant components(3): effect of pachyman, a main component of Poria cocos Wolf on original-type anti-GBM nephritis in rats and its mechanisms. Jpn J Pharmacol 59:89–96PubMedCrossRef Hattori T, Hayashi K, Nagao T (1992) Studies on antinephritic effects of plant components(3): effect of pachyman, a main component of Poria cocos Wolf on original-type anti-GBM nephritis in rats and its mechanisms. Jpn J Pharmacol 59:89–96PubMedCrossRef
13.
Zurück zum Zitat Bensky D, Barolet R (eds) (1990) Chinese herbal medicine: Formulas & Strategies. Eastland, Seatle, Washington Bensky D, Barolet R (eds) (1990) Chinese herbal medicine: Formulas & Strategies. Eastland, Seatle, Washington
14.
Zurück zum Zitat Chen YC, Ho CY, Chen LD, Hsu SF, Chen WC (2007) Wu-Ling-San formula inhibits the crystallization of calcium oxalate in vitro. Am J Chin Med 35:533–541PubMedCrossRef Chen YC, Ho CY, Chen LD, Hsu SF, Chen WC (2007) Wu-Ling-San formula inhibits the crystallization of calcium oxalate in vitro. Am J Chin Med 35:533–541PubMedCrossRef
15.
Zurück zum Zitat Nelde HJ, Bichler KH, Strohmaier WL (1988) Nephrocalcinosis in the kidney of the rat on atherogenic diet and the efffect of calcium antagonists (nifedipine). In: Bichler KN, Strohmaier WL (eds) Nephrocalcinosis calcium antagonists and kidney, Springer-Verlag, Berlin pp 113–125 Nelde HJ, Bichler KH, Strohmaier WL (1988) Nephrocalcinosis in the kidney of the rat on atherogenic diet and the efffect of calcium antagonists (nifedipine). In: Bichler KN, Strohmaier WL (eds) Nephrocalcinosis calcium antagonists and kidney, Springer-Verlag, Berlin pp 113–125
16.
Zurück zum Zitat Lee YH, Chang LS, Chen MT (1991) Characterization of ethylene glycol induced urolithiasis modle in rats. J Urol ROC 2:518–524 Lee YH, Chang LS, Chen MT (1991) Characterization of ethylene glycol induced urolithiasis modle in rats. J Urol ROC 2:518–524
17.
Zurück zum Zitat Lee YH, Huang WC, Chiang H (1992) Determinant role of testosterone in the pathogenesis of urolithiasis in rats. J Urol 147:1134–1138PubMed Lee YH, Huang WC, Chiang H (1992) Determinant role of testosterone in the pathogenesis of urolithiasis in rats. J Urol 147:1134–1138PubMed
18.
Zurück zum Zitat Lee YH, Tsai JY, Huang JK (2000) Combined use of 30% lactose rich diet and 1% ethylene glycol: a new animal model for study of urolithiasis. J Urol ROC 11:149–154 Lee YH, Tsai JY, Huang JK (2000) Combined use of 30% lactose rich diet and 1% ethylene glycol: a new animal model for study of urolithiasis. J Urol ROC 11:149–154
19.
20.
Zurück zum Zitat Green ML, Hatch M, Freel RW (2005) Ethylene glycol induces hyperoxaluria without metabolic acidosis in rats. Am J Physiol Renal Physiol 289:F536–F543PubMedCrossRef Green ML, Hatch M, Freel RW (2005) Ethylene glycol induces hyperoxaluria without metabolic acidosis in rats. Am J Physiol Renal Physiol 289:F536–F543PubMedCrossRef
21.
Zurück zum Zitat Selvam R, Kalaiselvi P, Govindaraj A (2001) Effect of A. Lanata leaf extract and Vediuppu chunnam on the urinary risk factors of calcium oxalate urolithiasis during experimental hyperoxaluria. Pharmacol Res 43:89–92PubMedCrossRef Selvam R, Kalaiselvi P, Govindaraj A (2001) Effect of A. Lanata leaf extract and Vediuppu chunnam on the urinary risk factors of calcium oxalate urolithiasis during experimental hyperoxaluria. Pharmacol Res 43:89–92PubMedCrossRef
22.
Zurück zum Zitat Das I, Gupta SK, Ansari SA (2005) In vitro inhibition and dissolution of calcium oxalate by edible plant Trianthema monogyna and pulse Macrotyloma uniflorum extracts. J Cryst Growth 273:546–554CrossRef Das I, Gupta SK, Ansari SA (2005) In vitro inhibition and dissolution of calcium oxalate by edible plant Trianthema monogyna and pulse Macrotyloma uniflorum extracts. J Cryst Growth 273:546–554CrossRef
23.
Zurück zum Zitat Viel TA, Domingos CD, Monteriro APS (1999) Evaluation of the antiurolithiatic activity of the extract of Costus spiralis Roscoe in rats. J Ethnopharmacol 66:193–198CrossRef Viel TA, Domingos CD, Monteriro APS (1999) Evaluation of the antiurolithiatic activity of the extract of Costus spiralis Roscoe in rats. J Ethnopharmacol 66:193–198CrossRef
24.
Zurück zum Zitat Gohel MDI, Wong SP (2006) Chinese herbal medicines and their efficacy in treating renal stones. Urol Res 34:365–372PubMedCrossRef Gohel MDI, Wong SP (2006) Chinese herbal medicines and their efficacy in treating renal stones. Urol Res 34:365–372PubMedCrossRef
25.
Zurück zum Zitat Cao ZG, Liu JH, Zhou SW (2004) The effect of the active constituents of Alisma orientalis on renal stone formation and bikunin expression in rat urolithiasis model. Matl Med J China 84:1276–1279 Cao ZG, Liu JH, Zhou SW (2004) The effect of the active constituents of Alisma orientalis on renal stone formation and bikunin expression in rat urolithiasis model. Matl Med J China 84:1276–1279
26.
Zurück zum Zitat Suzuki K, Kawamura K, Tsugawa R (1999) Formation and growth inhibition of calcium oxalate crystals by Takusha (Alismatis rhizoma). Scanning Microsc 13:183–189 Suzuki K, Kawamura K, Tsugawa R (1999) Formation and growth inhibition of calcium oxalate crystals by Takusha (Alismatis rhizoma). Scanning Microsc 13:183–189
27.
Zurück zum Zitat Yin CP, Liu JH, Zhang YS (1997) Effects of Alisma orientalis Juzep on calcium oxalate crystallization in vitro and calcium oxalate renal stone in rats. Acta Univ Med Tongji 26:99–101 Yin CP, Liu JH, Zhang YS (1997) Effects of Alisma orientalis Juzep on calcium oxalate crystallization in vitro and calcium oxalate renal stone in rats. Acta Univ Med Tongji 26:99–101
28.
Zurück zum Zitat Wang SY, Deng CQ, Shi ZL (2003) Influcence of Rhizoma alismatis on inhibition of renal stone formation. J Guangzhou Univ Tradit Chin Med 20:294–296 Wang SY, Deng CQ, Shi ZL (2003) Influcence of Rhizoma alismatis on inhibition of renal stone formation. J Guangzhou Univ Tradit Chin Med 20:294–296
29.
Zurück zum Zitat Yasui T, Fujita K, Sato M (1999) The effect of takusha, a kampo medicine, on renal stone formation and osteopontin expression in a rat urolithiasis model. Urol Res 27:194–199PubMedCrossRef Yasui T, Fujita K, Sato M (1999) The effect of takusha, a kampo medicine, on renal stone formation and osteopontin expression in a rat urolithiasis model. Urol Res 27:194–199PubMedCrossRef
30.
Zurück zum Zitat Yashimura K, Miake O, Okuyama A (1998) Effect of chorei-to and gorei-san on calcium oxalate crystallization in human urine. Hinyokika Kiyo 44:13–16 Yashimura K, Miake O, Okuyama A (1998) Effect of chorei-to and gorei-san on calcium oxalate crystallization in human urine. Hinyokika Kiyo 44:13–16
31.
Zurück zum Zitat Wesson JA, Johnson RJ, Mazzali M (2003) Osteopontin is a critical inhibitor of Calcium oxalate crystal formation and retension in renal tubules. J Am Soc Nephrol 14:139–147PubMedCrossRef Wesson JA, Johnson RJ, Mazzali M (2003) Osteopontin is a critical inhibitor of Calcium oxalate crystal formation and retension in renal tubules. J Am Soc Nephrol 14:139–147PubMedCrossRef
32.
Zurück zum Zitat Grover PK, Dogra SC, Davidson BP (2000) The prothrombin gene is expressed in the rat kidney: implications for urolithiasis research. Eur J Biochem 267:61–67PubMedCrossRef Grover PK, Dogra SC, Davidson BP (2000) The prothrombin gene is expressed in the rat kidney: implications for urolithiasis research. Eur J Biochem 267:61–67PubMedCrossRef
33.
Zurück zum Zitat Kumar V, Lieske JC (2006) Protein regulation of intrarenal crystallization. Curr Opin Nephrol Hypertens 15:374–380PubMedCrossRef Kumar V, Lieske JC (2006) Protein regulation of intrarenal crystallization. Curr Opin Nephrol Hypertens 15:374–380PubMedCrossRef
34.
Zurück zum Zitat Umekawa T, Chegini N, Khan SR (2003) Increase expression of monocyte chemoattractant protein-1(MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Nephrol Dial Transplant 18:664–669PubMedCrossRef Umekawa T, Chegini N, Khan SR (2003) Increase expression of monocyte chemoattractant protein-1(MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Nephrol Dial Transplant 18:664–669PubMedCrossRef
35.
Zurück zum Zitat Umekawa T, Hatanaka Y, Kurita T (2004) Effect of angiotensinII receptor blocakge on osteoponton expression and calcium oxalate crystal deposition in rat kidneys. J Am Soc Nephrol 15:653–644CrossRef Umekawa T, Hatanaka Y, Kurita T (2004) Effect of angiotensinII receptor blocakge on osteoponton expression and calcium oxalate crystal deposition in rat kidneys. J Am Soc Nephrol 15:653–644CrossRef
36.
Metadaten
Titel
A traditional Chinese herbal antilithic formula, Wulingsan, effectively prevents the renal deposition of calcium oxalate crystal in ethylene glycol-fed rats
verfasst von
Chou-Huang Tsai
Yu-Cheng Chen
Lieh-Der Chen
Tien-Chien Pan
Chien-Yi Ho
Ming-Tsung Lai
Fuu-Jen Tsai
Wen-Chi Chen
Publikationsdatum
01.02.2008
Verlag
Springer-Verlag
Erschienen in
Urolithiasis / Ausgabe 1/2008
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-007-0122-4

Weitere Artikel der Ausgabe 1/2008

Urolithiasis 1/2008 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.